Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01061268 · ClinicalTrials.gov registry record · Phase 4

A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens

A Phase 4 study, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase
25
Enrollment target

NCT01061268 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01061268, a Phase 4 study, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase
25 participants
Enrollment target

Study Summary

To evaluate the safety and efficacy of BLINK™ tears compared with NO topical artificial tear use in improving subject's visual performance and reduce ocular symptoms of discomfort in subjects who have undergone cataract surgery implanted with a Tecnis™ diffractive multifocal intraocular lens (IOL).

Interventions

  • DRUG No topical artificial tear
  • DRUG Blink® Tears Lubricant Eye Drops

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2010-01
Est. Completion 2012-02
Phase Phase 4

Sponsor

Innovative Medical

44 total trials

What the Registry Record Tells You About NCT01061268

The ClinicalTrials.gov registry entry for NCT01061268 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which No topical artificial tear is the first listed.

NCT01061268 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01061268 about?

NCT01061268 is a clinical study titled "A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens". To evaluate the safety and efficacy of BLINK™ tears compared with NO topical artificial tear use in improving subject's visual performance and reduce ocular symptoms of discomfort in subjects who have undergone cataract surgery implanted with a Tecnis™ diffractive multifocal intraocular lens (IOL).

What is the current status of trial NCT01061268?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2010-01. Estimated completion is 2012-02.

What interventions are being tested in trial NCT01061268?

The interventions under investigation include: No topical artificial tear (DRUG), Blink® Tears Lubricant Eye Drops (DRUG).

Who is sponsoring clinical trial NCT01061268?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.